IUPHAR/BPS Guide to Pharmacology CITE
https://doi.org/10.2218/gtopdb/F257/2023.1
Adenylyl cyclases (ACs) in GtoPdb v.2023.1
Carmen W. Dessauer1,
Rennolds Ostrom2,
Roland Seifert3 and
Val J. Watts4
- University of Texas Health Science Center, USA
- Chapman University, USA
- Medical School of Hannover, Germany
- Purdue University, USA
Abstract
Adenylyl cyclase, E.C. 4.6.1.1, converts ATP to cyclic AMP and pyrophosphate. Mammalian membrane-delimited adenylyl cyclases (nomenclature as approved by the NC-IUPHAR Subcommittee on Adenylyl cyclases [11]) are typically made up of two clusters of six TM domains separating two intracellular, overlapping catalytic domains that are the target for the nonselective activators Gαs (the stimulatory G protein α subunit) and forskolin (except AC9, [28]). adenosine and its derivatives (e.g. 2',5'-dideoxyadenosine), acting through the P-site,are inhibitors of adenylyl cyclase activity [35]. Four families of membranous adenylyl cyclase are distinguishable: calmodulin-stimulated (AC1, AC3 and AC8), Ca2+- and Gβγ-inhibitable (AC5, AC6 and AC9), Gβγ-stimulated and Ca2+-insensitive (AC2, AC4 and AC7), and forskolin-insensitive (AC9) forms. A soluble adenylyl cyclase (AC10) lacks membrane spanning regions and is insensitive to G proteins.It functions as a cytoplasmic bicarbonate (pH-insensitive) sensor [7].
Contents
This is a citation summary for Adenylyl cyclases (ACs) in the
Guide to Pharmacology
database (GtoPdb). It exists purely as an adjunct to the database to
facilitate the recognition of citations to and from the database by
citation analyzers. Readers will almost certainly want to visit the
relevant sections of the database which are given here under database
links.
GtoPdb is an expert-driven
guide to pharmacological targets and the substances that act on them.
GtoPdb is a reference work which is most usefully represented as an
on-line database. As in any publication this work should be
appropriately cited, and the papers it cites should also be
recognized. This document provides a citation for the relevant parts
of the database, and also provides a reference list for the research
cited by those parts. For further details see [4].
Please note that the database version for the citations given in
GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially
changed. The links below are to the current version. If you
need to consult the cited version, rather than the most recent version, please contact
the GtoPdb curators.
Database links
Adenylyl cyclases (ACs)
https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=257
Enzymes
AC1(adenylyl cyclase 1)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1278
AC2(adenylyl cyclase 2)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1279
AC3(adenylyl cyclase 3)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1280
AC4(adenylyl cyclase 4)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1281
AC5(adenylyl cyclase 5)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1282
AC6(adenylyl cyclase 6)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1283
AC7(adenylyl cyclase 7)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1284
AC8(adenylyl cyclase 8)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1285
AC9(adenylyl cyclase 9)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1286
AC10(adenylyl cyclase 10)
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3068
References
- Beeler JA, Yan SZ, Bykov S, Murza A, Asher S and Tang WJ. (2004) A soluble C1b protein and its regulation of soluble type 7 adenylyl cyclase. Biochemistry 43: 15463-71 [PMID:15581358]
- Brand CS, Hocker HJ, Gorfe AA, Cavasotto CN and Dessauer CW. (2013) Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther 347: 265-75 [PMID:24006339]
- Brust TF, Alongkronrusmee D, Soto-Velasquez M, Baldwin TA, Ye Z, Dai M, Dessauer CW, van Rijn RM and Watts VJ. (2017) Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci Signal 10 [PMID:28223412]
- Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
- Cali JJ, Zwaagstra JC, Mons N, Cooper DM and Krupinski J. (1994) Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 269: 12190-5 [PMID:8163524]
- Chen J and Iyengar R. (1993) Inhibition of cloned adenylyl cyclases by mutant-activated Gi-alpha and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment. J Biol Chem 268: 12253-6 [PMID:8389756]
- Chen Y, Cann MJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR and Buck J. (2000) Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 289: 625-8 [PMID:10915626]
- Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G and Iyengar R. (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci USA 94: 14100-4 [PMID:9391159]
- Choi EJ, Xia Z and Storm DR. (1992) Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry 31: 6492-8 [PMID:1633161]
- Conley JM, Brand CS, Bogard AS, Pratt EP, Xu R, Hockerman GH, Ostrom RS, Dessauer CW and Watts VJ. (2013) Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor. J Pharmacol Exp Ther 347: 276-87 [PMID:24008337]
- Dessauer CW, Watts VJ, Ostrom RS, Conti M, Dove S and Seifert R. (2017) International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacol Rev 69: 93-139 [PMID:28255005]
- Diel S, Klass K, Wittig B and Kleuss C. (2006) Gbetagamma activation site in adenylyl cyclase type II. Adenylyl cyclase type III is inhibited by Gbetagamma. J Biol Chem 281: 288-94 [PMID:16275644]
- Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS and Feldman RD. (2004) Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol Pharmacol 66: 921-8 [PMID:15385642]
- Gao BN and Gilman AG. (1991) Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc Natl Acad Sci USA 88: 10178-82 [PMID:1946437]
- Gao X, Sadana R, Dessauer CW and Patel TB. (2007) Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits. J Biol Chem 282: 294-302 [PMID:17110384]
- Hess KC, Jones BH, Marquez B, Chen Y, Ord TS, Kamenetsky M, Miyamoto C, Zippin JH, Kopf GS and Suarez SS et al.. (2005) The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Dev Cell 9: 249-59 [PMID:16054031]
- Hill J, Howlett A and Klein C. (2000) Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6. Cell Signal 12: 233-7 [PMID:10781930]
- Ishikawa Y, Katsushika S, Chen L, Halnon NJ, Kawabe J and Homcy CJ. (1992) Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J Biol Chem 267: 13553-7 [PMID:1618857]
- Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ and Ishikawa Y. (1995) Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 270: 12481-4 [PMID:7759492]
- Jacobowitz O, Chen J, Premont RT and Iyengar R. (1993) Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem 268: 3829-32 [PMID:8440678]
- Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ and Ishikawa Y. (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269: 16554-8 [PMID:8206971]
- Lai HL, Lin TH, Kao YY, Lin WJ, Hwang MJ and Chern Y. (1999) The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C. Mol Pharmacol 56: 644-50 [PMID:10462552]
- Litvin TN, Kamenetsky M, Zarifyan A, Buck J and Levin LR. (2003) Kinetic properties of "soluble" adenylyl cyclase. Synergism between calcium and bicarbonate. J Biol Chem 278: 15922-6 [PMID:12609998]
- Lustig KD, Conklin BR, Herzmark P, Taussig R and Bourne HR. (1993) Type II adenylylcyclase integrates coincident signals from Gs, Gi, and Gq. J Biol Chem 268: 13900-5 [PMID:8390980]
- Miller M, Rossetti T, Ferreira J, Ghanem L, Balbach M, Kaur N, Levin LR, Buck J, Kehr M and Coquille S et al.. (2022) Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates. J Med Chem 65: 15208-15226 [PMID:36346696]
- Onda T, Hashimoto Y, Nagai M, Kuramochi H, Saito S, Yamazaki H, Toya Y, Sakai I, Homcy CJ and Nishikawa K et al.. (2001) Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms. J Biol Chem 276: 47785-93 [PMID:11602596]
- Paterson JM, Smith SM, Simpson J, Grace OC, Sosunov AA, Bell JE and Antoni FA. (2000) Characterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/Calcineurin and differential mRNA plyadenylation. J Neurochem 75: 1358-67 [PMID:10987815]
- Premont RT, Matsuoka I, Mattei MG, Pouille Y, Defer N and Hanoune J. (1996) Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem 271: 13900-7 [PMID:8662814]
- Ramos-Espiritu L, Kleinboelting S, Navarrete FA, Alvau A, Visconti PE, Valsecchi F, Starkov A, Manfredi G, Buck H and Adura C et al.. (2016) Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase. Nat Chem Biol 12: 838-44 [PMID:27547922]
- Robbins JD, Boring DL, Tang WJ, Shank R and Seamon KB. (1996) Forskolin carbamates: binding and activation studies with type I adenylyl cyclase. J Med Chem 39: 2745-52 [PMID:8709105]
- Sinnarajah S, Dessauer CW, Srikumar D, Chen J, Yuen J, Yilma S, Dennis JC, Morrison EE, Vodyanoy V and Kehrl JH. (2001) RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409: 1051-5 [PMID:11234015]
- Tang WJ, Krupinski J and Gilman AG. (1991) Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J Biol Chem 266: 8595-603 [PMID:2022671]
- Taussig R, Quarmby LM and Gilman AG. (1993) Regulation of purified type I and type II adenylylcyclases by G protein beta gamma subunits. J Biol Chem 268: 9-12 [PMID:8416978]
- Taussig R, Tang WJ, Hepler JR and Gilman AG. (1994) Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem 269: 6093-100 [PMID:8119955]
- Tesmer JJ, Dessauer CW, Sunahara RK, Murray LD, Johnson RA, Gilman AG and Sprang SR. (2000) Molecular basis for P-site inhibition of adenylyl cyclase. Biochemistry 39: 14464-71 [PMID:11087399]
- Watson PA, Krupinski J, Kempinski AM and Frankenfield CD. (1994) Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J Biol Chem 269: 28893-8 [PMID:7961850]
- Wayman GA, Impey S and Storm DR. (1995) Ca2+ inhibition of type III adenylyl cyclase in vivo. J Biol Chem 270: 21480-6 [PMID:7665559]
- Willoughby D, Halls ML, Everett KL, Ciruela A, Skroblin P, Klussmann E and Cooper DM. (2012) A key phosphorylation site in AC8 mediates regulation of Ca(2+)-dependent cAMP dynamics by an AC8-AKAP79-PKA signalling complex. J Cell Sci 125: 5850-9 [PMID:22976297]
- Yoshimura M and Cooper DM. (1992) Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 89: 6716-20 [PMID:1379717]
- Zimmermann G and Taussig R. (1996) Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and betagamma subunits. J Biol Chem 271: 27161-6 [PMID:8900209]